SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news

 

 
HIGHLIGHTS FROM PROBIOTA 2017 IN BERLIN

Is pharma interest in probiotics a challenge or opportunity?

By Nathan Gray+

06-Mar-2017
Last updated on 06-Mar-2017 at 11:43 GMT2017-03-06T11:43:57Z

Is pharma interest in probiotics a challenge or opportunity?

The probiotic category continues to grow rapidly on a global basis. And with growth comes increased interest probiotics and microbiome modulation therapies from the pharmaceutical sector. But is this increased interest a good thing for the traditional probiotic players?

The recent Probiota event in Berlin  brought together leading experts in research and business to discuss the state of play in probiotics, prebiotics and microbiome modification.

NutraIngredients asked for expert insights on a range of topics. Here we asked experts from the business and research world whether increased interest in the microbiome and probiotics from big pharmaceutical is a challenge or opportunity for long-established probiotics researchers and suppliers.

Susanne Baekgaard of Bifodan told us that the use of drug development technologies and methodologies for the development of probiotic strains and science 'can be beneficial', while Amy Smith of DuPont said the probiotic industry working with the pharmaceutical industry is 'very promising' and "could really make a difference in people's lives."

"Probiotics, as they are today, are generally used as dietary supplements where they can be manufactured according to dietary supplement GMPs, and crossing the line over to the world of pharmaceuticals would mean a difference in manufacturing where pharmaceutical GMPs would have to be followed and there would be a change in the manufacturing process," said Smith.

VIDEO: From earthquakes to sourcing strife - the challenges to open the world’s newest omega-3 fish oil refinery

VIDEO: From earthquakes to sourcing strife - the challenges to open the world’s newest omega-3 fish oil refinery

Omega-3 fish oil supplier SeaDragon overcame a raft of challenges to open the world's...

Nutraceutical innovation around boosting or reducing nitric oxide

Nutraceutical innovation around boosting or reducing nitric oxide

Industry interest in boosting nitric oxide, a potent vasodilator, has been increasing, with companies...

Milk protein producer not ready throw in towel to whey

Milk protein producer not ready throw in towel to whey

Milk proteins continue to carve out a strong niche in sports nutrition despite’s whey...

Just Thrive Probiotic chosen for HIV trial, company says

Just Thrive Probiotic chosen for HIV trial, company says

Thrive Probiotic has gathered data on the company’s Just Thrive Probiotic supplement and its...

Synbio ingredients have vast market penetration, new list shows

Synbio ingredients have vast market penetration, new list shows

Synthetic biology, or GMO 2.0 as some are calling it, has vastly more penetration...

FOODVISION: Trust and ethics key to reaching consumer hearts and minds

FOODVISION: Trust and ethics key to reaching consumer hearts and minds

Erin Boyd Kappelhof

Managing Partner, Eat Well Global

FOODVISION: DNA testing just ‘one part of the jigsaw’

FOODVISION: DNA testing just ‘one part of the jigsaw’

Andrew Steele

Head of Product Development, DNAFit

From marketing to taste: How virtual reality will change the food industry

From marketing to taste: How virtual reality will change the food industry

Virtual reality has arrived and is set to change the way the food industry...

Is pharma interest in probiotics a challenge or opportunity?

Is pharma interest in probiotics a challenge or opportunity?

The probiotic category continues to grow rapidly on a global basis. And with growth...

Overcoming the taboo of vaginal health – the next frontier of probiotics

Overcoming the taboo of vaginal health – the next frontier of probiotics

A paradigm shift is needed to force delicate women’s health issues like vaginal infections...

FiE 2015: Our best bits

FiE 2015: Our best bits

Our teams of journalists were out in force at Food Ingredients Europe (FiE) last...

New tech on EFSA’s horizon: Crowdsourcing and cyber assistants

New tech on EFSA’s horizon: Crowdsourcing and cyber assistants

New technology like crowdsourcing and artificial intelligence computers is the future of risk assessment,...

EFSA’s Bernhard Url: Science should reserve one private room for open debate

EFSA’s Bernhard Url: Science should reserve one private room for open debate

Since taking the European Food Safety Authority (EFSA) throne last summer, Dr Bernhard Url has become...

Seadragon sets out to breathe fire into Kiwi fish oil

Seadragon sets out to breathe fire into Kiwi fish oil

The town of Nelson will welcome New Zealand's first omega-3 fish oil processing plant...

The taste test: How do you make a probiotic drink taste good?

The taste test: How do you make a probiotic drink taste good?

Probiotic fruit drinks face different challenges to their dairy counterparts - but both face...

African probiotic project reaching 10,000 infants a day

African probiotic project reaching 10,000 infants a day

Professor Gregor Reid

Chair , University of Western Ontario & Human Microbiology and...

Germvangelist set to shake Probiota with holistic shout

Germvangelist set to shake Probiota with holistic shout

Jason Tetro

Researcher, author, The Germ Guy

Creepy proteins will be hot

New proteins are creeping on trend

Alternative proteins are a “hot area” of interest and products such as sandwich spreads...

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Jake Riddle

General manager, Kerry Asia Pacific